Bibliography
- But DY, Lai CL, Yuen MF. Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol 2008;14(11):1652-6
- Lau WY. A review on the operative techniques in liver resection. Chin Med J 1997;110:567-70
- Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-9
- Leung TW, Patt YZ, Lau WY, et al. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res 1999;5:1676-81
- Gollob JA, Wilhelm S, Carter C, et al. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. Semin Oncol 2006;33:392-406
- Caraglia M, Tassone P, Marra M, et al. Targeting raf-kinase: molecular rationales and translational issues. Ann Oncol. 2006;17 Suppl 7:vii, 124-7
- Llovet J, Mazzaferro V, Ricci S, et al. Sorafenib improves survival in a large multi-center, randomized, placebo-controlled Phase III trial in patients with hepatocellular carcinoma [Abstract #3507]. Presented at: ECCO 23 – 27 September 2007; Barcelona, Spain. Eur J Cancer Suppl 2007;5:261
- Cheng A, Kang Y, Chen Z, et al. Randomized Phase III trial of sorafenib versus placebo in Asian patients with advanced hepatocellular carcinoma [Abstract 4509]. J Clin Oncol 2008;26(Suppl)
- Abou-Alfa GK, Amadori D, Santoro A, et al. Is sorafinib (S) safe and effective in patients (pts) with hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis [Abstract 140]? Gastrointestinal Cancers Symposium ASCO; 2008
- Llovet JM, Bruix J. Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008;48(4):1312-27
- Deli A, Kreidl E, Santifaller S, et al. Activins and activin antagonists in hepatocellular carcinoma. World J Gastroenterol 2008;14:1699-709
- Abou-alfa GK, Venook AP. The impact of new data in the treatment of advanced hepatocellular carcinoma. Curr Oncol Rep 2008;10:199-205